Shari L. Sutor

ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Catherine J. Huntoon, Karen S. Flatten, Andrea E. Wahner Hendrickson et al. · Cancer Research · 2013 · 209 citations · Full text

Medicine, Oncology, Pharmacology +17

Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors

Poorval Joshi, Shari L. Sutor, Catherine J. Huntoon et al. · Journal of Biological Chemistry · 2014 · 204 citations · Full text

Medicine, Molecular Biology, Oncology +12

Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Larry M. Karnitz, Shari L. Sutor, Toshihiko Torigoe et al. · Molecular and Cellular Biology · 1992 · 172 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Interleukin-2 Triggers a Novel Phosphatidylinositol 3-Kinase-Dependent MEK Activation Pathway

Larry M. Karnitz, L A Burns, Shari L. Sutor et al. · Molecular and Cellular Biology · 1995 · 145 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Severe Osteogenesis Imperfecta in Cyclophilin B–Deficient Mice

Jae Won Choi, Shari L. Sutor, Lonn D. Lindquist et al. · PLoS Genetics · 2009 · 97 citations · Full text

Medicine, Genetics, Molecular Biology +17